igf-1 lr3 pharmacology (1 MG) QK041 - Recombinant human/bovine/porcine IGF-1
Description
A.SchulzK.et al (2024)
JDS Commun
By simulating the hypoxic microenvironment or regulating the activity of molecules such as HIF-1, a series of adaptive changes are induced in immune cells, thereby improving disease symptoms and improving patients quality of life
The peptide is associated with changes in the hypothalamic-pituitary-adrenal axis, and this may play role in suicidal patients with major depressive disorder with altered DSIP-like immunoreactivity levels
